access to medicines

Digital

Reuters Pharma Europe 2025: Access, AI dominate keynote talk...

The opening sessions of Reuters Pharma Europe 2025 focused on global access challenges and the transformative potential of AI.

R&D

Delivery: The key to navigating pharmacy deserts in 2025

Pharmacy closures are accelerating fast.

R&D

Collaborative perseverance to bring change to medicine acces...

Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and Casper Paardekooper, partner at Vintura.

Patients

Will EU patients get the right treatment after legislation?

The EU’s proposal for a revision of the general pharmaceutical legislation aims to ensure EU citizens have access to affordable medicines and that unmet medical needs are addressed – all wh

News

Medicines Patent Pool, Novartis pen deal to boost access to ...

The Medicines Patent Pool (MPP) and Novartis have unveiled a new

News

Most pharma firms doing little R&D for poorer patients

A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.